24 Sep by Vitaliy Dadalyan InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects VANCOUVER, BC, Sept. 24, 2020 /CNW/ – InMed Pharmaceuticals Inc.
